New substituted C-19-andrographolide analogues with potent cytotoxic activities. 2012

Uthaiwan Sirion, and Sakkasem Kasemsook, and Kanoknetr Suksen, and Pawinee Piyachaturawat, and Apichart Suksamrarn, and Rungnapha Saeeng
Department of Chemistry and Center for Innovation in Chemistry, Faculty of Science, Burapha University, Chonburi 20131, Thailand.

Andrographolide, the major diterpenoid lactone from Andrographis paniculata, is toxic against cancer cells. In the present study, we investigated the structure-activity relationships (SARs) of 19 andrographolide analogues which were synthesized by modification at the three hydroxyl groups. A number of the andrographolide analogues showed much higher cytotoxic activities than that of the parent compound on cancer cells including P-388, KB, COL-2, MCF-7, LU-1 and ASK cells. SAR studies of the synthetic analogues indicated that the introduction of silyl ether or triphenylmethyl ether group into C-19 of the parent compound led to increase in toxicity against the cancer cells. The 19-O-triphenylmethyl ether analogue 18 showed higher cytotoxic activity than the potent anticancer drug ellipticine, and this analogue may serve as a potential structure lead for the development of new anticancer drugs.

UI MeSH Term Description Entries
D007783 Lactones Cyclic esters of hydroxy carboxylic acids, containing a 1-oxacycloalkan-2-one structure. Large cyclic lactones of over a dozen atoms are MACROLIDES. Lactone
D008956 Models, Chemical Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Chemical Models,Chemical Model,Model, Chemical
D002626 Chemistry, Pharmaceutical Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use. Medicinal Chemistry,Chemistry, Pharmaceutic,Pharmaceutic Chemistry,Pharmaceutical Chemistry,Chemistry, Medicinal
D004224 Diterpenes Twenty-carbon compounds derived from MEVALONIC ACID or deoxyxylulose phosphate. Diterpene,Diterpenes, Cembrane,Diterpenes, Labdane,Diterpenoid,Labdane Diterpene,Norditerpene,Norditerpenes,Norditerpenoid,Cembranes,Diterpenoids,Labdanes,Norditerpenoids,Cembrane Diterpenes,Diterpene, Labdane,Labdane Diterpenes
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Uthaiwan Sirion, and Sakkasem Kasemsook, and Kanoknetr Suksen, and Pawinee Piyachaturawat, and Apichart Suksamrarn, and Rungnapha Saeeng
April 2006, Journal of enzyme inhibition and medicinal chemistry,
Uthaiwan Sirion, and Sakkasem Kasemsook, and Kanoknetr Suksen, and Pawinee Piyachaturawat, and Apichart Suksamrarn, and Rungnapha Saeeng
May 2009, Journal of medicinal chemistry,
Uthaiwan Sirion, and Sakkasem Kasemsook, and Kanoknetr Suksen, and Pawinee Piyachaturawat, and Apichart Suksamrarn, and Rungnapha Saeeng
December 2013, Archives of pharmacal research,
Uthaiwan Sirion, and Sakkasem Kasemsook, and Kanoknetr Suksen, and Pawinee Piyachaturawat, and Apichart Suksamrarn, and Rungnapha Saeeng
July 2007, Journal of medicinal chemistry,
Uthaiwan Sirion, and Sakkasem Kasemsook, and Kanoknetr Suksen, and Pawinee Piyachaturawat, and Apichart Suksamrarn, and Rungnapha Saeeng
July 2014, ChemMedChem,
Uthaiwan Sirion, and Sakkasem Kasemsook, and Kanoknetr Suksen, and Pawinee Piyachaturawat, and Apichart Suksamrarn, and Rungnapha Saeeng
February 2021, Bioorganic & medicinal chemistry letters,
Uthaiwan Sirion, and Sakkasem Kasemsook, and Kanoknetr Suksen, and Pawinee Piyachaturawat, and Apichart Suksamrarn, and Rungnapha Saeeng
January 2011, Scientia pharmaceutica,
Uthaiwan Sirion, and Sakkasem Kasemsook, and Kanoknetr Suksen, and Pawinee Piyachaturawat, and Apichart Suksamrarn, and Rungnapha Saeeng
March 2007, Phytochemistry,
Uthaiwan Sirion, and Sakkasem Kasemsook, and Kanoknetr Suksen, and Pawinee Piyachaturawat, and Apichart Suksamrarn, and Rungnapha Saeeng
July 2009, European journal of medicinal chemistry,
Uthaiwan Sirion, and Sakkasem Kasemsook, and Kanoknetr Suksen, and Pawinee Piyachaturawat, and Apichart Suksamrarn, and Rungnapha Saeeng
June 2015, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!